Back

Predictors of long term tricuspid regurgitation after pulmonary valve replacement: a single center study on the cohort of significant preoperative tricuspid regurgitation.

26 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Surgery and intervention in congenital heart disease: moving forward Adult Congenital Heart Disease (ACHD) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Barbara Carbonell Prat

University Hospital Vall d'Hebron, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Percutaneous edge-to-edge repair for systemic tricuspid valve regurgitation in patients with congenital heart disease: the first descriptive cohort
Doctor M. Ladouceur (Le Plessis Robinson, FR)
Abstract Slides
Presentation thumbnail
Is bilateral lung transplantation in pulmonary artery hypertension related to congenital heart disease a real therapeutic option? Experience of a national referral centre
Doctor R. Luna (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Outcome of device atrial septal defect closure in different age groups: a nationwide cohort study
Doctor V. Muroke (Montreal, CA)
Abstract Slides
Presentation thumbnail
Single predictor of residual right-to-left shunt to optimally select patients for suture-mediated percutaneous patent fossa ovalis closure
Doctor C. Gaspardone (Milan, IT)
Abstract Slides
Presentation thumbnail
Conservative vs surgical management in ebstein's anomaly: long-term follow-up in a real-life cohort
Doctor C. Merino Argos (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Surgery and intervention in congenital heart disease: moving forward

The Event

Event poster

ESC Congress 2022

26 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources